Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @pharmaphorum
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @pharmaphorum
-
New analysis reveals the 3 key trends that have shaped the
#immunology market over the last decade and will continue to impact the industry over the next few years https://bit.ly/2RXpkcf pic.twitter.com/kBZ2oyeVqF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Just under 24 hours to go until our next webinar with
@Complete_hv - don't forget to sign up for this educational, informative debate https://bit.ly/39Aaqzh#pharma#medcomms#chronicdiseases#behaviouralsciencepic.twitter.com/Eif3zl3zgn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Merck & Co
$MRK takes a leaf out of Pfizer and GSK’s playbook, spinning off slower-growth products, including generics, biosimilars and women’s health drugs with annual sales of $6.5bn, into a new company https://bit.ly/2ulF1Ru@MerckHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A pleasure to be invited to take part, thanks
@PhilippeKirby (and with relevant attribution on this slide to friends at@healthware_intl)
^PThttps://twitter.com/PhilippeKirby/status/1225008601913352194 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks to today's panel and to
@mdgroupintl and Plenum for a great discussion - if you missed out, you can now view this debate on demand https://bit.ly/2PWQFZO#pharma#medcomms#patientengagement#medicalinformationprogrammes#clinicaltrialspic.twitter.com/BS4CVUMNg6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
93% of life sciences companies are developing more content than they were 2 years ago so how can this content be measured to produce more personalised materials? Download
@Veeva_EU’s recent ebook to find out http://bit.ly/2Rq2N7M#contentjourney#digitalsupplychain#pharmapic.twitter.com/K0tlEbLvFf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
That's it for today's webinar! If you missed anything you can watch again at the link below. Thanks to
@mdgroupintl and Plenum for partnering with us on this presentation https://www.brighttalk.com/webcast/9977/381930?utm_campaign=my-channels-feed&utm_content=&utm_source=brighttalk-portal&utm_medium=web …#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dominic Jack says it takes time for organisations to change, but things are already better than they were 3 or even 2 years ago
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We need to take a broader consumer approach, including to people not yet diagnosed with a condition
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Andrew: Why shouldn't HCPs wear a badge that says 'ask me about clinical trials?'
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Rafe says that the sector need to be more active in contacting patients
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Rafe says medical societies can help patients teach other patients
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We've been talking about patient centricity for years now but not about patient education. There's a lot than can be done
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Change needs to come from all kinds of stakeholders, such as HCPs and regulators as well as pharma
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
There should be measures put in place to overcome disparities and make sure everyone who wants to take part in a clinical trial can
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vale says we might see more medical associations and patient groups promote more education on clinical trials
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How are we going to get to the future we want to see in patient involvement?
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For education, pharma companies usually assume the more information you provide the more accurate it is. But simpler messages can sometimes get through to patients better
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dominic says it's still 'small scale' in Europe
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Despite loosening rules they've been very tentative and slow
#pharma#medcomms#patientengagement#ppwebinarHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.